NEWS

For our visitors who seek the latest industry news and updates to keep up with the goings-on of the business on a global scale, this portal grants a dynamic and diverse feed of news items contemporaneous with the current affairs of the Pharmaceutical Industry.

news

Novartis drug zykadia receives fda priority review for first-line use in patients with alk+ metastatic nsclc. Says novartis drug zykadia receives fda priority review for first-line use in patients with alk+ metastatic nsclc. Says fda also grants breakthrough therapy designation based on phase iii data in previously untreated alk+ metastatic…

news

Danish biotech drugmaker Genmab expects sales of Darzalex, used to fight cancer in bone marrow, to surpass $1 billion this year to become a blockbuster drug, the company said on Wednesday. The strong performance of Darzalex, which is currently approved to treat multiple myeloma, prompted six upward revisions to the…

news

Alimera Sciences, Inc., a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, and Knight Therapeutics Inc., a leading Canadian specialty pharmaceutical company, today announced that Knight's New Drug Submission (NDS) for ILUVIEN® has been accepted for review by Health Canada. ILUVIEN (fluocinolone acetonide intravitreal implant) 0.19 mg is…

news

Trevena Inc said on Tuesday that its lead experimental drug oliceridine outperformed a placebo in two late-stage studies in patients suffering from acute pain. The intravenous formulation was being tested in patients with moderate-to-severe acute pain following bunionectomy and abdominoplasty.   Source: reuters.com

news

Pfizer announces acceptance of regulatory submission for inotuzumab ozogamicin by the U.S. Food and Drug Administration. Says prescription drug user fee act (PDUFA) goal date for a decision by FDA is in August 2017. Pfizer - marketing authorization application for inotuzumab ozogamicin in same patient population currently under review by…

news

Sun Pharma's first production unit in Egypt involving a total investment of USD 12.5 million was today inaugurated, signalling growing bussines ties between India and the key Middle East nation. India's Ambassador to Egypt Sanjay Bhattacharyya inaugurated Ranbaxy Egypt factory in 6th October City, the first production of Sun Pharma…

news

Takeda Pharmaceutical Co Ltd Says the co plans to transfer domestic consumer healthcare business to its wholly owned unit, a Tokyo-based medical supplies firm. Says effective April 1.   Source: reuters.com

news

Norwegian biotech newcomer Nordic Nanovector (NANOV.OL), which seeks ways to treat blood-related cancers, says other companies are showing interest in buying the firm. "We talk a lot with companies, and as the data improves and the company develops, the more interest we have, that's for sure," chief executive officer Luigi…

news

In 2013 when Ranbaxy, one of India’s oldest drug companies, agreed to the US Department of Justice’s (DOJ’s) charge of wrongdoing in its manufacturing process, a $500 million fine seemed like a small price to pay for what was coming. Ranbaxy became a stick for global competitors of Indian drug…

news

Shanghai Pharmaceuticals Holding Co Ltd Says co's controlling bio-pharmaceuticals unit receives GMP certificate from Shanghai Food and Drug Administration. Certificate is issued to plants of APIs (paclitaxel and docetaxel) in the unit and the valid period is until Jan. 21, 2022.   Source: reuters.com